Center for Outcomes & Policy Research

The Center for Outcomes and Policy Research (COPR) at the Dana-Farber Cancer Institute aims to enhance the experiences and outcomes of patients through rigorous research on health outcomes and policy. Investigators assess the clinical efficacy, effectiveness and cost-effectiveness of interventions to prevent and treat cancer.

Decision Systems Group

The Decision Systems Group (DSG) at the Brigham and Women’s Hospital conducts research in computer-based decision support, information retrieval, clinical information systems, image-based reasoning, bioinformatics, and machine learning applications, including the development of algorithms, software environments, and computer-based tools.

Department of Health Care Policy

The Department of Health Care Policy is an academic department within the Harvard Medical School specializing in health policy. Research includes broad topics on financing and delivery of health care, quality of care, studies on special and disadvantaged populations and access to care and methods contributions in statistics and biostatistics.

Division of Health Policy & Insurance

The Division of Health Policy & Insurance Research (HPI) within the Department of Population Medicine at the Harvard Medical School conducts rigorous research to inform the development of health policies and health systems innovations that improve access to care and health outcomes in the U.S. and globally.

Evaluation of Value & Risk in Health

The Center for Evaluation of Value and Risk in Health (CEVR) is a member of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston. The mission of CEVR is to analyze the benefits, risks, and costs of strategies to improve health and health care and to communicate the findings to clinicians and policymakers.

Harvard Center for Risk Analysis

The Harvard Center for Risk Analysis (HCRA) at the Harvard T.H. Chan School of Public Health conducts state-of-the-art research, educates the next generation of leaders in risk analysis, and encourages public discourse about risk topics to improve decisions about environmental health and other risks.

Health Decision Sciences Center

The Health Decision Sciences Center (HDSC) at the Massachusetts General Hospital is committed to improving the quality of decisions made by patients and health care providers. Research focuses on developing, implementing, and evaluating decision aids and decision quality measures to support shared decision-making in medical encounters.

Harvard Decision Science Laboratory

The Harvard Decision Science Laboratory at the Harvard Kennedy School of Government is an advanced research facility that creates and supports a community of scholars working in the many intersecting areas of Decision Science.  They provide a critical resource to researchers from across Harvard University.

Institute for Quantitative Social Science

The Institute for Quantitative Social Science (IQSS) at the Harvard FAS builds cutting edge social science infrastructure to foster a community of social scientists, establishing large-scale Harvard-wide partnerships to develop expertise and products such as the Harvard Dataverse and Applied Statistics Workshop series.

Institute for Technology Assessment

The Institute for Technology Assessment (ITA) at the Massachusetts General Hospital conducts research to guide the development, evaluation and utilization of technologies that improve the quality and cost-effectiveness of medical care. Areas of focus include decision analysis, economic evaluation, and health-related quality of life.

Moral Psychology Research Lab

The Moral Psychology Research Lab at the Harvard Faculty of Arts & Sciences investigates how people learn and make decisions in social contexts, particularly focusing on moral judgment and decision making.  They use methods that include surveys, economic games, functional neuroimaging, and computational modeling.

Prevention Policy Modeling Lab

The Prevention Policy Modeling Lab at the School of Public Health models the impact, costs and cost-effectiveness of infectious disease treatment & prevention in the U.S., incorporating evidence-based prevention strategies, emphasizing cross-cutting initiatives, and producing results that can be operationalized in health and other sectors.